| 1 | [SID16953363] | Active | IC50 | 0.628 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | 0.628 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 2 | [SID16953363] | Active | IC50 | 0.628 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | 0.628 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 3 | [SID16953363] | Active | IC50 | 0.628 | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen [AID624343, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | 0.628 [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a PAF-induced IL8 counterscreen | | AID | 624343 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 4 | [SID144089005] | Active | IC50 | 4 | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay [AID651592_8, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 144089005 | | CID | 2064400 | | Outcome | Active | | IC50 | 4 [uM] | | BioAssay | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 651592 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 5 | [SID144089005] | Active | IC50 | 4 | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay [AID651592_8, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 144089005 | | CID | 2064400 | | Outcome | Active | | IC50 | 4 [uM] | | BioAssay | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 651592 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 6 | [SID16953363] | Active | AC50 | 8.842 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | AC50 | 8.842 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 7 | [SID16953363] | Active | AC50 | 8.842 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | AC50 | 8.842 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 8 | [SID16953363] | Active | AC50 | 8.842 | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity [AID540270, Type: confirmatory] | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | AC50 | 8.842 [uM] | | BioAssay | HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540270 | | BioAssay type | confirmatory | | Target | heat shock protein HSP 90-alpha isoform 2 [Homo sapiens] [gi:154146191] | | PubMed | | | Data Table |  |
|
| 9 | [SID16953363] | Active | EC50 | 9.357 | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response [AID1047, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | EC50 | 9.357 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Dose Response | | AID | 1047 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID16953363] | Active | EC50 | 13.507 | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response [AID1045, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | EC50 | 13.507 [uM] | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Dose Response | | AID | 1045 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID16953363] | Active | AC50 | 18.141 | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity [AID540268, Type: confirmatory] | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | AC50 | 18.141 [uM] | | BioAssay | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540268 | | BioAssay type | confirmatory | | Target | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] | | PubMed | | | Data Table |  |
|
| 12 | [SID16953363] | Active | Potency | 22.3872 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 13 | [SID16953363] | Active | IC50 | 24.187 | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage [AID588779, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | 24.187 [uM] | | BioAssay | Dose response confirmation of uHTS hits for small molecule modulators of myocardial damage | | AID | 588779 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID16953363] | Active | Potency | 39.8107 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 15 | [SID16953363] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 16 | [SID144089005] | Active | IC50 | 66 | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay [AID651592_15, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 144089005 | | CID | 2064400 | | Outcome | Active | | IC50 | 66 [uM] | | BioAssay | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 651592 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 17 | [SID144089005] | Active | IC50 | 66 | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay [AID651592_15, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 144089005 | | CID | 2064400 | | Outcome | Active | | IC50 | 66 [uM] | | BioAssay | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 651592 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 18 | [SID16953363] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 19 | [SID16953363] | Active | | | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID588850, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 588850 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 20 | [SID16953363] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 21 | [SID16953363] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_1, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 22 | [SID16953363] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 23 | [SID16953363] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 24 | [SID16953363] | Active | | | uHTS identification of small molecule modulators of myocardial damage [AID588492, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS identification of small molecule modulators of myocardial damage | | AID | 588492 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID16953363] | Active | | | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor [AID827, Type: screening] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor | | AID | 827 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID16953363] | Active | | | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression [AID818, Type: screening] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression | | AID | 818 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID16953363] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay [AID504607, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay | | AID | 504607 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID16953363] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 29 | [SID16953363] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 30 | [SID16953363] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 31 | [SID16953363] | Active | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 32 | [SID16953363] | Active | | | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1 [AID1304, Type: screening] | neuropeptide Y receptor Y1 [Homo sapiens] [gi:4505445] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1 | | AID | 1304 | | BioAssay type | screening | | Target | neuropeptide Y receptor Y1 [Homo sapiens] [gi:4505445] | | PubMed | | | Data Table |  |
|
| 33 | [SID16953363] | Active | | | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1 [AID1304, Type: screening] | neuropeptide Y receptor Y1 [Homo sapiens] [gi:4505445] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y1 | | AID | 1304 | | BioAssay type | screening | | Target | neuropeptide Y receptor Y1 [Homo sapiens] [gi:4505445] | | PubMed | | | Data Table |  |
|
| 34 | [SID16953363] | Active | | | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2 [AID1359, Type: screening] | neuropeptide Y receptor Y2 [Homo sapiens] [gi:4505447] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2 | | AID | 1359 | | BioAssay type | screening | | Target | neuropeptide Y receptor Y2 [Homo sapiens] [gi:4505447] | | PubMed | | | Data Table |  |
|
| 35 | [SID16953363] | Active | | | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2 [AID1359, Type: screening] | neuropeptide Y receptor Y2 [Homo sapiens] [gi:4505447] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for potentiators or agonists of NPY-Y2 | | AID | 1359 | | BioAssay type | screening | | Target | neuropeptide Y receptor Y2 [Homo sapiens] [gi:4505447] | | PubMed | | | Data Table |  |
|
| 36 | [SID16953363] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 37 | [SID16953363] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 38 | [SID16953363] | Active | | | CYP2C9 Assay [AID777, Type: screening] | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | CYP2C9 Assay | | AID | 777 | | BioAssay type | screening | | Target | cytochrome P450, family 2, subfamily C, polypeptide 9 [Homo sapiens] [gi:13699818] | | PubMed | | | Data Table |  |
|
| 39 | [SID16953363] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_4, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 40 | [SID16953363] | Active | IC50 | | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay [AID624344_4, Type: confirmatory] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 624344 | | BioAssay type | confirmatory | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 41 | [SID16953363] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 42 | [SID16953363] | Active | | | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay [AID602472, Type: screening] | CFTR gene product [Homo sapiens] [gi:90421313] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for cystic fibrosis induced NFkb Inhibitors in a fluoresence assay | | AID | 602472 | | BioAssay type | screening | | Target | CFTR gene product [Homo sapiens] [gi:90421313] | | PubMed | | | Data Table |  |
|
| 43 | [SID16953363] | Active | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 44 | [SID16953363] | Active | | | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay [AID602244, Type: screening] | CXCR6 gene product [Homo sapiens] [gi:5730106] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay | | AID | 602244 | | BioAssay type | screening | | Target | CXCR6 gene product [Homo sapiens] [gi:5730106] | | PubMed | | | Data Table |  |
|
| 45 | [SID16953363] | Active | | | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity [AID504582, Type: screening] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504582 | | BioAssay type | screening | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 46 | [SID16953363] | Active | | | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID504621, Type: screening] | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 504621 | | BioAssay type | screening | | Target | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] | | PubMed | | | Data Table |  |
|
| 47 | [SID16953363] | Active | | | uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay [AID463212, Type: screening] | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay | | AID | 463212 | | BioAssay type | screening | | Target | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] | | PubMed | | | Data Table |  |
|
| 48 | [SID16953363] | Active | | | Single concentration confirmation of small molecule inhibitors of tim23-1 yeast via a luminescent assay [AID463218, Type: screening] | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 16953363 | | CID | 2064400 | | Outcome | Active | | BioAssay | Single concentration confirmation of small molecule inhibitors of tim23-1 yeast via a luminescent assay | | AID | 463218 | | BioAssay type | screening | | Target | TPA: Tim23p [Saccharomyces cerevisiae S288c] [gi:285814664] | | PubMed | | | Data Table |  |
|
| 49 | [SID144089005] | Unspecified | IC50 | 2.612 | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay [AID651592_9, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 144089005 | | CID | 2064400 | | Outcome | Unspecified | | IC50 | 2.612 [uM] | | BioAssay | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 651592 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|
| 50 | [SID144089005] | Unspecified | IC50 | 2.612 | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay [AID651592_9, Type: confirmatory] | IL8 gene product [Homo sapiens] [gi:10834978] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 144089005 | | CID | 2064400 | | Outcome | Unspecified | | IC50 | 2.612 [uM] | | BioAssay | SAR analysis of molecule cystic fibrosis induced NFkb Inhibitors in a panel assay | | AID | 651592 | | BioAssay type | confirmatory | | Target | IL8 gene product [Homo sapiens] [gi:10834978] | | PubMed | | | Data Table |  |
|